Vanguard Capital Management
VCYT icon

Vanguard Capital Management’s Veracyte VCYT Stock Holding History

Vanguard Capital Management’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211M Buy
3,593,922
+61,690
+2% +$2.59M ﹤0.01% 1098
2026
Q1 		$114M Buy
+3,532,232
New +$131M ﹤0.01% 1400

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management's VCYT Position: Q2 2026 in Review

Vanguard Capital Management increased its Veracyte (VCYT) stake by 1.7% in Q2 2026, buying an estimated $2.59M and bringing the position to 3,593,922 shares worth $211M. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

Vanguard Capital Management first reported a position in VCYT in Q1 2026 and has held it in 2 quarters since. 368 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Vanguard Capital Management held 3,593,922 shares of Veracyte worth $211M as of Q2 2026.
  • Vanguard Capital Management bought 61,690 Veracyte shares in Q2 2026, an estimated $2.59M.
  • Veracyte made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #1098 holding.
  • Vanguard Capital Management first reported a position in Veracyte in Q1 2026 and has held it in 2 quarters since.
  • 368 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.